BAX/BCL2 ratio in chronic lymphocytic leukemia and its association with ZAP-70 expression and other clinicopathological parameters
BACKGROUND: Chronic lymphocytic leukemia (CLL) is a heterogeneous disease with a highly variable clinical course and outcome. Many clinical and biological characteristics have been used to classify patients with CLL into different subgroups of variable prognosis. Many studies have reported that in C...
Main Authors: | Rihab Malik Rahid, Maysem Mouayad Alwash |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Iraqi Journal of Hematology |
Subjects: | |
Online Access: | http://www.ijhonline.org/article.asp?issn=2072-8069;year=2020;volume=9;issue=1;spage=34;epage=40;aulast=Rahid |
Similar Items
-
Association of Bax expression and Bcl2/Bax ratio with clinical and molecular prognostic markers in chronic lymphocytic leukemia
by: Vučićević Ksenija, et al.
Published: (2016-01-01) -
Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy?
by: Kulsoom B, et al.
Published: (2018-03-01) -
The role of Bcl-2 protein, Bax protein and there ratio in peripheral blood lymphocytes of asthmatic patients
by: Israa F. Jaffar, et al.
Published: (2008-07-01) -
Expressão das proteínas BCL-2 e BAX em tumores astrocíticos humanos Expression of BCL-2 and BAX proteins in human astrocytic tumors
by: Mário Henrique Girão Faria, et al.
Published: (2006-08-01) -
Evaluation of Bcl2/BAX genes expression ratio as a marker of inflammatory bowel disease
by: Fariba Javadinia, et al.
Published: (2019-06-01)